BioSpace News Archive

CARsgen Therapeutics Inc. announced the United States Food and Drug Administration has granted orphan drug designation to its investigational CAR-T cell therapy fully human anti-BCMA autologous chimeric antigen receptor T Cells for the treatment of multiple myeloma.

The global chronic fatigue syndrome therapeutics market size is poised to grow by USD 44.31 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of more than 4% during the forecast period.

Oncopeptides AB announced that new updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study will be presented at at the 17th International Myeloma Workshop meeting on September 15, Boston, Massachusetts, USA.

The global smart pills market size is poised to reach USD 212.97 million by 2023, according to a new report by Technavio, progressing at a CAGR of over 10% during the forecast period.

Innovent Biologics, Inc. announced that the clinical trial results of IBI303, an anti-tumor necrosis factor-alpha monoclonal antibody injection developed by Innovent, has been published in The Lancet Rheumatology, a leading international medical journal, with comment by Stanley Cohen, professor of University of Texas Southwestern Medical Center.

AAC Holdings, Inc. announced financial results for the second quarter and six months ended June 30, 2019, as well as updated 2019 guidance.

Prostate cancer is the second most common cancer for men, both in the United States and worldwide.

Sophiris Bio Inc. (Nasdaq: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced the completion of its previously announced registered direct offering of 5,333,334 common shares

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019 at 10:30 am ET at the Grand Hyatt in New York City.

Walgreens is taking proactive measures to assist customers, team members and communities in the projected path of Hurricane Dorian, and is preparing to fully support impacted regions in the storm’s aftermath